Audun Tornes
Hoofd Techniek/Wetenschap/O&O bij ULTIMOVACS ASA
Vermogen: 74 989 $ op 31-05-2024
Momenteel actieve connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Hans Vassgård Eid | M | 57 | - | |
| Anne Hovi Worsøe | F | 60 | 3 jaar | |
| Gudrun Trøite | M | - | - | |
| Carlos de Sousa | M | 66 | 4 jaar | |
| Olav Steinnes | M | 67 |
Inven2 AS
 Inven2 AS Investment ManagersFinance Inven2 AS (Inven2) is the venture capital subsidiary of the University of Oslo and Oslo University Hospital, Norway's largest pioneering research university and hospital. The firm was created in 2010 when technology transfer company Birkeland Innovasjon AS and investment development firm Medinnova merged. Located in Oslo, Inven2 manages the Inven2 Fund, commercializing innovations, administering the fund and conducting and following up clinical trials. | 13 jaar |
| Antonius Berkien | M | 56 | 4 jaar | |
| Ingunn Hagen Westgaard | F | - | - | |
| Haakon Stenrod | M | 44 | 4 jaar | |
| Jens Bjørheim | M | - | - | |
| Øivind Foss | M | - | - | |
| Kari Grønås | F | 59 | 5 jaar | |
| Gustav Gaudernack | M | - | - | |
| Ole Kristian Hjelstuen | M | - |
Inven2 AS
Inven2 AS Investment ManagersFinance Inven2 AS (Inven2) is the venture capital subsidiary of the University of Oslo and Oslo University Hospital, Norway's largest pioneering research university and hospital. The firm was created in 2010 when technology transfer company Birkeland Innovasjon AS and investment development firm Medinnova merged. Located in Oslo, Inven2 manages the Inven2 Fund, commercializing innovations, administering the fund and conducting and following up clinical trials. | 12 jaar |
| Henrik Schüssler | M | 61 | 9 jaar | |
| Ole Kristian Skaar | M | - |
Inven2 AS
Inven2 AS Investment ManagersFinance Inven2 AS (Inven2) is the venture capital subsidiary of the University of Oslo and Oslo University Hospital, Norway's largest pioneering research university and hospital. The firm was created in 2010 when technology transfer company Birkeland Innovasjon AS and investment development firm Medinnova merged. Located in Oslo, Inven2 manages the Inven2 Fund, commercializing innovations, administering the fund and conducting and following up clinical trials. | 13 jaar |
| Jónas Einarsson | M | 67 | 13 jaar | |
| Mc Callion Orla | M | - | 3 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Jostein Christian Dalland | M | 55 |
Inven2 AS
Inven2 AS Investment ManagersFinance Inven2 AS (Inven2) is the venture capital subsidiary of the University of Oslo and Oslo University Hospital, Norway's largest pioneering research university and hospital. The firm was created in 2010 when technology transfer company Birkeland Innovasjon AS and investment development firm Medinnova merged. Located in Oslo, Inven2 manages the Inven2 Fund, commercializing innovations, administering the fund and conducting and following up clinical trials. | 1 jaar |
Statistieken
| Land | Connecties | % van het totaal |
|---|---|---|
| Noorwegen | 18 | 100.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Audun Tornes
- Persoonlijk netwerk
